Kelun-Biotech Announces Results from the SKB264-II-06/MK-2870-002 Study of Sacituzumab Tirumotecan (Sac-TMT) in Gynecologic Oncology Presented at 2026 SGO

Kelun-Biotech Announces Results from the SKB264-II-06/MK-2870-002 Study of Sacituzumab Tirumotecan (Sac-TMT) in Gynecologic Oncology Presented at 2026 SGO

CHENGDU, China, April 14, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that results from both the ovarian cancer cohort and the cervical cancer cohort of Phase II study...

China Automotive Systems to Announce Unaudited 2025 Fourth Quarter and Audited 2025 Year Financial Results on April 22, 2026

China Automotive Systems to Announce Unaudited 2025 Fourth Quarter and Audited 2025 Year Financial Results on April 22, 2026

WUHAN, China, April 13, 2026 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that it will issue unaudited financial results...

Former UK Ministry of Defence Chief Data and AI Officer Joins Strider

Former UK Ministry of Defence Chief Data and AI Officer Joins Strider

LONDON, April 13, 2026 /PRNewswire/ -- Strider Technologies, Inc., the leading provider of strategic intelligence, today announced that Caroline Bellamy, former Chief Data and AI Officer at the UK Ministry of Defence (MoD), has joined the company as...

Telix and Regeneron Announce Strategic Radiopharma Collaboration

Telix and Regeneron Announce Strategic Radiopharma Collaboration

Telix and Regeneron to co-develop and co-commercialize next-generation radiopharmaceutical therapies in a 50/50 cost and profit-sharing model. Collaboration combines Telix's expertise in radiopharmaceutical development and manufacturing with...

111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Continuing Transition to an Asset-Light Business Model to Improve Overall Efficiency Delivered Non-GAAP Operating Profitability in Both Q4'25 and FY'25 Generated Positive Operating Cash Flow for Both Q4'25 and FY'25 Continued Gross Profit Margin...

Boysen Unveils 'Color Stories': Transforming Limitless Paint Colors into Interactive Filipino Narratives

Boysen Unveils 'Color Stories': Transforming Limitless Paint Colors into Interactive Filipino Narratives

MAKATI CITY, Philippines, April 8, 2026 /PRNewswire/ -- Boysen, the Philippines' leading paint brand, in collaboration with creative agency TBWAMP, has officially launched Boysen Color Stories, a groundbreaking digital platform that transforms the...

Portrai to Present 11 Posters on AI-Driven Spatial Transcriptomics at AACR 2026

Portrai to Present 11 Posters on AI-Driven Spatial Transcriptomics at AACR 2026

The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug discovery. SEOUL, South Korea, April 8, 2026 /PRNewswire/ -- Portrai, Inc. today announced it will present 11 posters...

Ridgetech, Inc. Announces 1-for-150 Reverse Share Split

Ridgetech, Inc. Announces 1-for-150 Reverse Share Split

HANGZHOU, China, April 4, 2026 /PRNewswire/ -- Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (Nasdaq: RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to...

TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions

TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions

Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX's industry-leading global network of electronic health record data Collaboration will expand Regeneron's world-leading genomic and proteomic...

Sino Biological ProPure™ Endotoxin-Free Proteins: The "Invisible Guardian" of Biopharmaceuticals

Sino Biological ProPure™ Endotoxin-Free Proteins: The "Invisible Guardian" of Biopharmaceuticals

HOUSTON, April 1, 2026 /PRNewswire/ -- After months of meticulous work, your cells suddenly behave unpredictably, or your mouse models develop fever and systemic inflammation during critical studies. The hidden culprit may be endotoxin, the...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 57
  • menu
    menu